Intensity Therapeutics, Inc. Common stock Cash Flow-to-Debt Ratio
Intensity Therapeutics, Inc. Common stock cash flow-to-debt ratio. Intensity Therapeutics, Inc. Common stock (INTS) has a Cash Flow-to-Debt Ratio of -0.79x as of March 2026, meaning its operating cash flow of $-1.83 Million could theoretically repay -1% of its total liabilities ($2.31 Million) in one year. See INTS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Intensity Therapeutics, Inc. Common stock (2019–2025)
Cash flow-to-debt ratio of Intensity Therapeutics, Inc. Common stock from 2019 to 2025. Historical debt coverage capacity for Intensity Therapeutics, Inc. Common stock across 7 annual periods. Also explore Intensity Therapeutics, Inc. Common stoc net asset momentum to track the company's year-over-year net asset growth rate.
Intensity Therapeutics, Inc. Common stock Cash Flow-to-Debt Ratio by Year (2019–2025)
Intensity Therapeutics, Inc. Common stock cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Intensity Therapeutics, Inc. Common stock. For the full cash flow conversion analysis, see Intensity Therapeutics, Inc. Common stoc (INTS) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.15x | $-9.23 Million | $2.23 Million | ▲ +49.2% |
| 2024 | -8.16x | $-15.22 Million | $1.86 Million | ▼ -368.1% |
| 2023 | -1.74x | $-7.21 Million | $4.13 Million | ▼ -436.4% |
| 2022 | -0.32x | $-5.48 Million | $16.86 Million | ▲ +33.8% |
| 2021 | -0.49x | $-6.83 Million | $13.90 Million | ▼ -7.1% |
| 2020 | -0.46x | $-5.37 Million | $11.71 Million | ▲ +86.4% |
| 2019 | -3.38x | $-4.42 Million | $1.31 Million | — |